Morning Briefing
Summaries of health policy coverage from major news organizations
WellPoint Guidelines May Bolster Federal 'Comparative Effectiveness' Investments
The health insurer WellPoint has announced guidelines for using comparative effectiveness studies to pit drugs against one another and determine which works best.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
